SureTrader
Home > Boards > US Listed > Biotechs > Mast Therapeutics, Inc. (MSTX)

thanks appreciate the response, I am long here,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BISerNOMORE Member Profile
 
Followed By 65
Posts 5,348
Boards Moderated 0
Alias Born 03/17/10
160x600 placeholder
Mast Therapeutics To Present At 2016 BIO CEO & Investor Conference On February 8th "PR Newswire (US)" - 2/2/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/1/2016 5:18:38 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/1/2016 9:21:26 AM
Mast Therapeutics' AIR001 Selected By The Heart Failure Clinical Research Network For Evaluation In A 100-Patient Multicenter... "PR Newswire (US)" - 2/1/2016 9:10:00 AM
Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Prese... "PR Newswire (US)" - 2/1/2016 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/11/2016 8:02:35 AM
Mast Therapeutics Provides Business Update "PR Newswire (US)" - 1/7/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/7/2016 7:56:03 AM
Amended Statement of Beneficial Ownership (sc 13d/a) "Edgar (US Regulatory)" - 12/30/2015 5:02:03 PM
Mast Therapeutics To Present At The Piper Jaffray 27th Annual Healthcare Conference "PR Newswire (US)" - 11/24/2015 8:00:00 AM
Vepoloxamer Data Selected For Presentation At 57th Annual American Society Of Hematology (ASH) Meeting "PR Newswire (US)" - 11/16/2015 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/12/2015 5:43:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/12/2015 4:08:14 PM
Mast Therapeutics Reports Third Quarter 2015 Financial Results "PR Newswire (US)" - 11/12/2015 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/9/2015 4:54:50 PM
Vepoloxamer Nonclinical Study Results In Advanced Heart Failure To Be Presented At 2015 American Heart Association Scientific... "PR Newswire (US)" - 11/9/2015 8:15:00 AM
Mast Therapeutics Announces Appointment Of Peter Greenleaf To Board of Directors "PR Newswire (US)" - 11/9/2015 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/2/2015 6:13:32 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 11/2/2015 6:09:50 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/2/2015 4:18:04 PM
Mast Therapeutics Announces Appointment Of Matthew Pauls To Board Of Directors "PR Newswire (US)" - 11/2/2015 8:00:00 AM
Mast Therapeutics To Host Third Quarter 2015 Financial Results And Corporate Update Conference Call "PR Newswire (US)" - 10/29/2015 8:00:00 AM
Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure "PR Newswire (US)" - 10/26/2015 8:00:00 AM
BASF to Develop a High Purity Poloxamer for Mast Therapeutics "PR Newswire (US)" - 10/13/2015 10:57:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/7/2015 12:51:43 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist